title: SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis.
authors: Ulrich
authors: U
authors: Lehmann
authors: Stephan
authors: S
authors: Bartels
authors: Britta
authors: B
authors: Hasemeier
authors: Robert
authors: R
authors: Geffers
authors: Jerome
authors: J
authors: Schlue
authors: Guntram
authors: G
authors: Büsche
authors: Kais
authors: K
authors: Hussein
authors: Hans
authors: H
authors: Kreipe
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D058070:Asymptomatic Diseases; D002452:Cell Count; D005260:Female; D005355:Fibrosis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000502:physiology; D009687:Nuclear Proteins / Q000235:genetics*; D055728:Primary Myelofibrosis / Q000235:genetics* / Q000473:pathology; D012261:Ribonucleoproteins / Q000235:genetics*; D000068103:Serine-Arginine Splicing Factors
chemical_list: D009687:Nuclear Proteins; D012261:Ribonucleoproteins; C073288:SRSF2 protein, human; D000068103:Serine-Arginine Splicing Factors